1. Neoadjuvant niraparib in patients with HER2-negative, BRCA-mutated resectable breast cancer. (April 2021) Authors: Spring, L.M.; Han, H.; Hamilton, E.; Irie, H.; Santa-Maria, C.A.; Reeves, J.; Pan, P.; Shan, M.; Tang, Y.; Graham, J.R.; Hazard, S.; Ellisen, L.W.; Isakoff, S.J. Journal: Breast Issue: Volume 56(2021)Supplement 1 Page Start: S55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗